{
    "clinical_study": {
        "@rank": "134533", 
        "arm_group": {
            "arm_group_label": "lixisenatide", 
            "arm_group_type": "Experimental", 
            "description": "lixisenatide monotherapy by group (Group 1: 52-week treatment; Group 2: 24-week treatment)"
        }, 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To assess the overall safety of lixisenatide once daily treatment in monotherapy over 24 and\n      52 weeks in patients with type 2 diabetes in Japan\n\n      Secondary Objective:\n\n      To assess the effects of lixisenatide once daily treatment in monotherapy over 24 and 52\n      weeks on:\n\n        -  HbA1c (Glycated hemoglobin A1c) reduction;\n\n        -  Fasting plasma glucose;\n\n        -  Body weight."
        }, 
        "brief_title": "Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  Group 1: 60 weeks \u00b1 11 days\n\n        -  Group 2: 32 weeks \u00b1 7 days"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Patients with type 2 diabetes mellitus diagnosed for at least 2 months.\n\n          -  Not treated with anti-diabetic drug or treated with a stable dose of 1 oral\n             anti-diabetic drug (OAD) for at least 3 months prior to screening visit. Previous OAD\n             (if any) have to be stopped at Visit 1.1 to be washed out during the run-in period at\n             least for 6 weeks;\n\n          -  Signed written informed consent.\n\n        Exclusion criteria:\n\n          -  At screening\n\n          -  age <20 years;\n\n          -  HbA1c <7% or >9.5% (for patients on OAD <6.5% or >8.5%);\n\n          -  fasting plasma glucose >250 mg/dL (>13.9 mmol/L);\n\n          -  Use of more than one OAD within 3 months prior to screening;\n\n          -  Use of Thiazolidinedione (TZD) within 6 months prior to screening;\n\n          -  Use of insulin within 3 months prior to screening; Note: Short time use (\u226410 days) of\n             insulin due to acute illness or surgery (eg, infectious disease) is allowed.\n\n          -  Any previous treatment with lixisenatide (eg, participation in a previous study with\n             lixisenatide) or any other GLP-1 receptor agonist;\n\n          -  Type 1 diabetes mellitus\n\n          -  Women of childbearing potential with no effective contraceptive method;\n\n          -  Pregnancy or lactation;\n\n          -  Laboratory findings at the time of screening:\n\n        oAmylase and/or lipase >3 times the upper limit of the normal laboratory range (ULN);\n\n          -  ALT >3 ULN;\n\n          -  Calcitonin \u226520 pg/mL (5.9 pmol/L);\n\n          -  Positive serum pregnancy test in women of childbearing potential;\n\n          -  History of acute or chronic pancreatitis, pancreatectomy, stomach/gastric surgery,\n             inflammatory bowel disease;\n\n          -  Personal or immediate family history of medullary thyroid cancer (MTC) or genetic\n             conditions that predispose to MTC (eg, multiple endocrine neoplasia syndromes);\n\n          -  Allergic reaction to metacresol.\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "360", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960179", 
            "org_study_id": "SFY13476", 
            "secondary_id": "U1111-1134-2695"
        }, 
        "intervention": {
            "arm_group_label": "lixisenatide", 
            "description": "Pharmaceutical form:solution Route of administration: Subcutaneous injection", 
            "intervention_name": "lixisenatide AVE0010", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 15, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Adachi-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392006"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiba-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392005"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiyoda-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392010"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuo-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392015"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuo-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392004"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuoh-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392003"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ebina-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392012"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Higashiosaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392024"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kashiwara-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392023"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kawagoe-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392008"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kisarazu-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392009"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koganei-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392002"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koriyama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392007"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mitaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392011"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392026"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392025"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogawa-Machi, Hikigun", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392013"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ohta-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392014"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okawa-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392022"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392029"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392028"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392021"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sapporo-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392030"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sendai-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392018"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392001"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suita-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392020"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toshima-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392017"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toyonaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392027"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392016"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392019"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-label, Multicenter 24-Week And 52-Week Study Assessing The Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes", 
        "overall_contact": {
            "email": "Contact-Us@sanofi.com", 
            "last_name": "For site information, send an email with site number to"
        }, 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Safety over 24 and 52 weeks assessed by treatment emergent adverse event (TEAE), vital signs, 12-lead electrocardiogram (ECG), and laboratory data.", 
            "safety_issue": "Yes", 
            "time_frame": "from baseline to 24 weeks and 52 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960179"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Absolute change in HbA1c", 
                "safety_issue": "No", 
                "time_frame": "from baseline to week 24 and week 52"
            }, 
            {
                "measure": "Absolute change in fasting plasma glucose", 
                "safety_issue": "No", 
                "time_frame": "from baseline to week 24 and week 52"
            }, 
            {
                "measure": "Absolute change in body weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline to week 24 and week 52"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}